ロード中...
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on ‘Off’-time in Patients with Advanced Parkinson’s Disease: A Systematic Review
INTRODUCTION: Levodopa/carbidopa intestinal gel (LCIG; carbidopa/levodopa enteral suspension) has been widely used and studied for the treatment of motor fluctuations in levodopa-responsive patients with advanced Parkinson’s disease (PD) when other treatments have not given satisfactory results. Red...
保存先:
| 出版年: | Adv Ther |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Healthcare
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8189983/ https://ncbi.nlm.nih.gov/pubmed/34018146 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-021-01747-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|